Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06079203 · ClinicalTrials.gov registry record · NA
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care
A NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 19,200
- Enrollment target
- 1
- Study location
NCT06079203: Active NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia, sponsored by NYU Langone Health.
NCT06079203 is a NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 19,200 participants, above the 2,688-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (614% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06079203, a NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 19,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve the care of persons living with dementia (PLWD) and their informal care partners by addressing emergency and post-emergency care through different combinations of three PLWD-care partner dyad focused interventions. The primary aims are to use coaching to help connect PLWD and their care partners with community support and services to improve transitional care, quality of care, care satisfaction and reduce future ED visits and hospitalizations.
Conditions Studied
Interventions
- BEHAVIORAL Emergency Care Redesign (ECR)
- BEHAVIORAL Nurse-led Telephonic Care (NLTC)
- BEHAVIORAL Community Paramedic-led Transitions Intervention (CPTI)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,200 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What the registry record for NCT06079203 still lists
NCT06079203 is an interventional study that assigns participants to a tested intervention. Its 19,200 participants enrollment target places it among the larger protocols in the corpus, above the 2,688-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (614% higher).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which Emergency Care Redesign (ECR) is the first listed.
NCT06079203 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06079203 about?
NCT06079203 is a clinical study titled "ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care". The purpose of this study is to improve the care of persons living with dementia (PLWD) and their informal care partners by addressing emergency and post-emergency care through different combinations of three PLWD-care partner dyad focused interventions. The primary aims are to use coaching to help ...
What is the current status of trial NCT06079203?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 19,200 participants. The study started on 2025-09-02. Estimated completion is 2028-08-31.
What conditions does trial NCT06079203 study?
This clinical trial studies the following conditions: Alzheimer Disease, Alzheimer's Disease Related Dementia.
What interventions are being tested in trial NCT06079203?
The interventions under investigation include: Emergency Care Redesign (ECR) (BEHAVIORAL), Nurse-led Telephonic Care (NLTC) (BEHAVIORAL), Community Paramedic-led Transitions Intervention (CPTI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06079203?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06079203 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06079203's enrollment target sits among peer trials
19,200 7th of 306 higher than 300 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI